|
|
|
Pfizer Inc., which has faced chronic erosion of its top line due to increased competition from generic drugs, announced Tuesday that its research and development efforts to fill its pipeline are running ahead of schedule.
|
Trackback
|
Tags:
drugmaker
generic drugs
All
|
Category:
News
|
|
|
|
Comments